Page last updated: 2024-08-21

isoxazoles and Carcinoma, Ductal, Breast

isoxazoles has been researched along with Carcinoma, Ductal, Breast in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Balmaña, J; Cedrés, S; Cruz, C; Felip, E; Llop-Guevara, A; Mancuso, F; Martinez de Castro, A; Martinez-Marti, A; Miquel, JM; Navarro, A; Nuciforo, P; Pardo, N; Remon, J; Sansano, I; Serra, V; Vivancos, A; Zeron-Medina, J1
Chen, J; Jun, S; Jung, YS; Keyomarsi, K; Lee, S; Lin, SH; Park, BJ; Park, JI; Schneider, A; Sun Oh, Y; Wang, W; Wang, X1
Bishop-Bailey, D; Carpenter, R; Korbonits, M; Swales, KE; Walsh, DT; Warner, TD1

Other Studies

3 other study(ies) available for isoxazoles and Carcinoma, Ductal, Breast

ArticleYear
Activity of HSP90 Inhibiton in a Metastatic Lung Cancer Patient With a Germline BRCA1 Mutation.
    Journal of the National Cancer Institute, 2018, 08-01, Volume: 110, Issue:8

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; BRCA1 Protein; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Female; Gemcitabine; Germ-Line Mutation; HSP90 Heat-Shock Proteins; Humans; Isoxazoles; Lung Neoplasms; Maintenance Chemotherapy; Resorcinols; Treatment Outcome

2018
PAF-Wnt signaling-induced cell plasticity is required for maintenance of breast cancer cell stemness.
    Nature communications, 2016, Feb-04, Volume: 7

    Topics: Animals; Animals, Genetically Modified; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Carrier Proteins; Cell Line, Tumor; Cell Plasticity; DNA-Binding Proteins; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; HEK293 Cells; Humans; Hyperplasia; Immunoblotting; Isoxazoles; Kaplan-Meier Estimate; Mammary Glands, Animal; MCF-7 Cells; Mice; Neoplastic Stem Cells; Resorcinols; Tumor Stem Cell Assay; Wnt Signaling Pathway

2016
The farnesoid X receptor is expressed in breast cancer and regulates apoptosis and aromatase expression.
    Cancer research, 2006, Oct-15, Volume: 66, Issue:20

    Topics: Apoptosis; Aromatase; ATP Binding Cassette Transporter, Subfamily B; Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Line, Tumor; DNA-Binding Proteins; Humans; Hydroxysteroid Dehydrogenases; Isoxazoles; Ligands; Multidrug Resistance-Associated Protein 2; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Transcription Factors

2006